Pathos AI, a clinical-stage AI and technology company advancing its own pipeline of cancer therapies, today announced a licensing agreement with Jiangsu Alphamab Biopharmaceuticals Co., Ltd.

Pathos AI cancer drug deals worth up to $2.3 billion closed August 3, 2026, as the New York biotech licensed a dual-target ...

Market Intelligence analyst Jeff Lipton says overreliance on financial ratios can obscure forward-looking credit risks, making qualitative factors such as political willingness, management strategy, ...

What do you mean by olodo uprising? Who are you referring to exactly? Why are you trying to discredit content creators who ...

EFPIA has called for lawmakers to go beyond the reductions in clinical trial approval times proposed in the Biotech Act.

Here’s what to know.

This eligibility condition is perhaps one of its kind among the various cash transfer schemes for women, including those in other BJP-ruled states.

Anthropic's Claude AI has survived hack scandals and a massive US regulatory scare as the White House lifts export controls. It leads the race in the Best AI of 2026 prediction market, but can OpenAI ...

Explore the 10 best generative AI courses to take in 2026, with options for hands-on training, certifications, and practical ...

James Chen, CMT is an expert trader, investment adviser, and global market strategist. Somer G. Anderson is CPA, doctor of accounting, and an accounting and finance professor who has been working in ...

Ready to win big on the Arlington Million Stakes? Discover complete contender analysis, top value odds, and high-ROI trifecta strategies now!